Integrins and signaling in osteoclast function

Matrix Biology

Volumn 19, Issue 2, 2000, Pages 97-105

  Duong, Le T ^a   Lakkakorpi, Päivi ^a   Nakamura, Ichiro ^a   Rodan, Gideon A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Bone resorption; Cytoskeleton; Sealing zone; Tyrosine phosphorylation; Vitronectin receptor v 3

Indexed keywords

INTEGRIN;

BONE MATRIX; CELL ACTIVATION; CELL POLARITY; CELLULAR DISTRIBUTION; CYTOSKELETON; HUMAN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; OSTEOCLASTS; RECEPTORS, VITRONECTIN; SIGNAL TRANSDUCTION;

EID: 0034194652     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(00)00051-2     Document Type: Short Survey

References (59)

1. Berry V., Rathod H., Pulman L.B., Datta H.K. Immunofluorescent evidence for the abundance of focal adhesion kinase in the human and avian osteoclasts and its down regulation by calcitonin. J. Endocrinol. 141:1994;R11-15.
2. c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90:1992;1622-1627.
3. Buckley C.D., Doyonnas R., Newton J.P., Blystone S.D., Brown E.J., Watt S.M., Simmons D.L. Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1. J. Cell Sci. 109:1996;437-445.
4. Chambers T.J., Fuller K., Darby J.A., Pringle J.A.S., Horton M.A. Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro. Bone Miner. 1:1986;127-135.
5. Chellaiah M., Hruska K. Osteopontin stimulates gelsolin-associated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase. Mol. Biol. Cell. 7:1996;743-753.
6. Clark E.A., Brugge J.S. Integrins and signal transduction pathways: the road taken. Science. 268:1995;233-239.
7. Clover J., Dodds R.A., Gowen M. Integrin subunit expression by human osteoblasts and osteoclasts in situ and in culture. J. Cell Sci. 103:1992;267-271.
8. Crippes B.A., Engleman V.W., Settle S.L. et al. Antibody to β3 integrin inhibits osteoclast mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology. 137:1996;918-924.
9. Davies J., Warwick J., Totty N., Philp R., Helfrich M., Horton M. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J. Cell Biol. 109:1989;1817-1826.
10. Dodge J.A., Bryant H.U.J.K., Matter W.F. et al. 17β-hydroxywortmannin: a postent inhibitor of bone resorption and phosphatidyl 3-kinase. Bioorg. Med. Chem. Lett. 5:1995;1713-1718.
11. Duong L.T., Lakkakorpi P.T., Nakamura I., Machwate M., Nagy R.M., Rodan G.A. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of αvβ3 integrin, and phosphorylated by Src kinase. J. Clin. Invest. 102:1998;881-892.
12. Ebeling O., Duczmal A., Aigner S. et al. L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to αvβ3 integrin. Eur. J. Immunol. 26:1996;2508-2516.
13. Engleman V.W., Nickols G.A., Ross F.P. et al. A peptidomimetic antagonist of the αvβ3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J. Clin. Invest. 99:1997;2284-2292.
14. Fisher J.E., Caulfield M.P., Sato M. et al. Inhibition of osteoclastic bone resorption in vivo by echistatin, an 'arginyl-glycyl-aspartyl' (RGD)-containing protein. Endocrinology. 132:1993;1411-1413.
15. Flores M.E., Norgard M., Heinegard D., Reinholt F.P., Andersson G. RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin. Exp. Cell Res. 201:1992;526-530.
16. Flores M.E., Heinegard D., Reinholt F.P., Andersson G. Bone sialoprotein coated on glass and plastic surfaces is recognized by different β3 integrins. Exp. Cell Res. 227:1996;40-46.
17. Helfrich M.H., Nesbitt S.A., Dorey E.L., Horton M.A. Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a β3 integrin. J. Bone Miner. Res. 7:1992;335-343.
18. Helfrich M.H., Nesbitt S.A., Lakkakorpi P.T. et al. Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption. Bone. 19:1996;317-328.
19. Horton M.A. Vitronectin receptor: tissue specific expression or adaptation to culture. Int. J. Exp. Pathol. 71:1990;741-759.
20. Horton M.A. The alpha v beta 3 integrin 'vitronectin receptor'. Int. J. Biochem. Cell Biol. 29:1997;721-725.
21. Horton M.A., Rodan G.A. Integrins as therapeutic targets in bone disease. Horton M.A. Adhesion Receptors as Therapeutic Targets. 1996;223-245 CRC Press Inc, Boca Raton.
22. Horton M.A., Taylor M.L., Arnett T.R., Helfrich M.H. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp. Cell Res. 195:1991;368-375.
23. Hruska K.A., Rolnick F., Huskey M., Alvarez U., Cheresh D. Engagement of the osteoclast integrin αvβ3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Ann. N.Y. Acad. Sci. 760:1995;151-165.
24. Hultenby K., Reinholt F.P., Heinegard D. Distribution of integrin subunits on rat metaphyseal osteoclasts and osteoblasts. Eur. J. Cell Biol. 62:1993;86-93.
25. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
26. King K.L., D'Anza J.J., Bodary S. et al. Effects of kistrin on bone resorption in vitro and serum calcium in vivo. J. Bone Miner. Res. 9:1994;381-387.
27. Lakkakorpi P.T., Horton M.A., Helfrich M.H., Karhukorpi E.K., Väänänen H.K. Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J. Cell Biol. 115:1991;1179-1186.
28. Lakkakorpi P.T., Helfrich M.H., Horton M.A., Väänänen H.K. Spatial organization of microfilaments and vitronectin receptor αvβ3 in osteoclasts. A study using confocal laser scanning microscopy. J. Cell Sci. 104:1993;663-670.
29. Lakkakorpi P., Wesolowski G., Zimilo Z., Rodan G.A., Rodan S.B. Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading. Exp. Cell Res. 237:1997;296-306.
30. Lakkakorpi P., Nakamura I., Nagy R., Parsons J.T., Rodan G.A., Duong L.T. Stable association of PYK2 and p130cas in osteoclasts and their co-localization in the sealing zone. J. Biol. Chem. 274:1999;4900-4907.
31. Masarachia P., Yamamoto M., Rodan G.A., Duong L.T. Co-localization of the vitronectin receptor αvβ3 and echistatin in osteoclasts during bone resoption in vivo. J. Bone Miner. Res. 10:1995;S1647.
32. Masarachia P., Yamamoto M., Leu C.-T., Rodan G.A., Duong L.T. Direct demonstration of the inhibitory effect of echistatin on bone resorption in mice with secondary hyperparathyroidism. Endocrinology. 139:1998;1401-1410.
33. McHugh K.P., Hodivala-Dilke K., Cheng S.L. et al. The β3 integrin knockout mouse is osteosclerotic and has dysfunctional osteoblasts. Bone. 23:1998;S190.
34. Murphy M.A., Schnall R.G., Venter D.J. Tissue hyperplasia and enhanced T-cell signaling via ZAP-70 in c-Cbl deficient mice. Mol. Cell Biol. 18:1998;4872-4882.
35. Nakamura I., Takahashi N., Sasaki T. et al. Wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase, blocks osteoclastic bone resorption. FEBS Lett. 361:1995;79-84.
36. Nakamura I., Takahashi N., Sasaki T., Jimi E., Kurokawa T., Suda T. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts. J. Bone Miner. Res. 11:1996;1873-1879.
37. Nakamura I., Gailit J., Sasaki T. Osteoclast integrin αvβ3 is present in the clear zone and contributes to cellular polarization. Cell Tissue Res. 286:1996;507-5157.
38. cas is involved in actin organization in osteoclasts. J. Biol. Chem. 273:1998;11144-11149.
39. Nakamura I., Tanaka H., Rodan G.A., Duong L.T. Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells. Endocrinology. 139:1998;5182-5193.
40. Neff L., Amling M., Tanaka S., Gailit J., Baron R. Both the αv and β3 integrin subunits are present in the sealing zone of resorbing osteoclasts. J. Bone Miner. Res. 11:1996;S290.
41. Nesbitt S., Nesbit A., Helfrich M., Horton M. Biochemical characterization of human osteoclast integrins. Osteoclasts express αvβ3, α2β1, and αvβ1 integrins. J. Biol. Chem. 268:1993;16737-16745.
42. Paniccia R., Riccioni T., Zani B.M., Zigrino P., Scotlandi K., Teti A. Calcitonin down-regulates immediate cell signals induced in human osteoclast-like cells by the bone sialoprotein-IIA fragment through a post integrin receptor mechanism. Endocrinology. 136:1995;1177-1186.
43. Reinholt F.P., Hultenby K., Oldberg A., Heinegard D. Osteopontin - a possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. USA. 87:1990;4473-4475.
44. Ross F.P., Chappel J., Alvarez J.I. et al. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin αvβ3 potentiate bone resorption. J. Biol. Chem. 268:1993;9901-9907.
45. Sato M., Sardana M.K., Grasser W.A., Garsky V.M., Murray J.M., Gould R.J. Echistatin is a potent inhibitor of bone resorption in culture. J. Cell Biol. 111:1990;1713-1723.
46. Schlaepfer D.D., Hunter T. Integrin signalling and tyrosine phosphorylation: just the FAKs. Trends Cell Biol. 8:1998;151-157.
47. Shankar G., Davison I., Helfrich M.H., Mason W.T., Horton M.A. Integrin receptor-mediated mobilisation of intranuclear calcium in rat osteoclasts. J. Cell Sci. 105:1993;61-68.
48. Soriano P., Montgomery C., Geske R., Bradley A. Targeted disruption of the c-src protooncogene leads to osteopetrosis in mice. Cell. 64:1991;693-702.
49. Suda T., Nakamura I., Jimi E., Takahashi N. Regulation of osteoclast function. J. Bone Miner. Res. 12:1997;869-879.
50. FAK, in osteoclastic bone resorption. J. Cell. Biochem. 58:1995;424-435.
51. Tanaka S., Amling M., Neff L. et al. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature. 383:1996;528-531.
52. van der Pluijm G., Mouthaan H., Baas C., de Groot H., Papapoulos S., Lowik C. Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation. J. Bone Miner. Res. 9:1994;1021-1028.
53. Wennerberg K., Lohikangas L., Gullberg D., Plaff M., Johansson S., Fassler R. Beta 1 integrin-dependent and -independent polymerization of fibronectin. J. Cell Biol. 132:1996;227-238.
54. Wickham T.J., Mathias P., Cheresh D.A., Nemerow G.R. Integrin αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell. 73:1993;309-319.
55. Wu C., Hughes P.E., Ginsberg M.H., McDonald J.A. Identification of a new biological function for the integrin αvβ3: initiation of fibronectin matrix assembly. Cell Adh. Com. 4:1996;149-158.
56. Yamamoto M., Fisher J.E., Gentile M. et al. The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats. Endocrinology. 139:1998;1411-1419.
57. Zambonin Zallone A., Teti A., Gaboli M., Marchisio P.C. Beta 3 subunit of vitronectin receptor is present in osteoclast adhesion structures and not in other monocyte-macrophage derived cells. Connect. Tissue Res. 20:1989;143-149.
58. Zhang D., Udagawa N., Nakamura I. et al. The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts. J. Cell Sci. 108:1995;2285-2292.
59. Zimolo Z., Wesolowski G., Tanaka H., Hyman J.L., Hoyer J.R., Rodan G.A. Soluble αvβ3-integrin ligands raise [Ca2+] in rat osteoclasts and mouse-derived osteoclast-like cells. Am. J. Physiol. 266:1994;C376-C381.